MBX vs MSCI · $1.98B cap vs P/E 37, rev $1.72B
MBX Biosciences, Inc. Common Stock (MBX) versus MSCI Inc (MSCI) — a side-by-side from cached financials, not a winner call.
MBX Biosciences, Inc. Common Stock (MBX) is a biotechnology company listed on NASDAQ.
MSCI Inc (MSCI) is a financial data & stock exchanges company listed on US.
MBX does not have a complete income-statement cache yet.
Latest reported MSCI revenue for 2026-06-30 was $1.72B. Net income was $748.0M. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
MBX currently screens at market cap $1.98B. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
Not investment advice. Open the MBX and MSCI stock pages for the full models.
Not investment advice.